Background: Trachea is essential for ventilation and lesions that cause its stenosis impair this function. There are several causes of this injury and, although the most common benign cause is prolonged orotracheal intubation, diseases such as Tracheal Tuberculosis can progress with tracheal stenosis. The prevalence of tuberculosis-induced tracheobronchial stenosis is estimated at 10% to 40% and its diagnosis is suggested in the presence of a compatible clinic, confirmed by histopathological examination (obtained by bronchoscopy) or by positive culture of bacilli in the microbiological examination. The culture obtained by examination of sputum is less sensitive, generating false negative results, as in the described report. Method: Retrospective case report based on chart analysis and bronchoscopic evaluation Results: Female patient, 23 years old, in the 21st week of pregnancy with dyspnea and stridor for 2 years. She presents past Pulmonary Tuberculosis treatment with COXCIP scheme (Rifampicin, Isoniazid, Pyrazinamide, Etambutol) for 6 months. After end of treatment, she underwent three sputum smear microscopies, with negative results. A chest CT scan showed significant reduction of the tracheal lumen in the area next to the plane of the sternal furcula, extending to thoracic follow-up, becoming quite critical in the supracarinal region, until extension to the left bronchus-source. Bronchoscopy ratifies CT findings, evidencing edema and mucosal leukoplakia, with marked narrowing of the ostium of left bronchus-source. The treatment for Wegener's granulomatosis has started with Cyclophosphamide and Prednisone. New chest CT, after 10 months, evidences absence of regression of the stenosis. As the patient became pregnant during the investigation, she was referred to the High Risk Maternity, with replacement of Cyclophosphamide by Azathioprine, and association with inhaled corticoid. As the patient did not present a therapeutic response, she sought the Thoracic Surgery of the Hospital Universitário Oswaldo Cruz (HUOC-Recife) after episode of dyspnoea, cough and lymphocyte. Treatment for Tracheal Tuberculosis with COXCIP scheme was initiated again due to epidemiology, pathological antecedent and patient's condition. Conclusion: In pregnancy, tracheal stenosis can arise and significantly affect maternal and fetal oxygenation and ventilation. It is necessary to perform its treatment according to clinical presentation, degree of stenosis, gestational phase and maternal-fetal safety. Despite the efficacy of the drug for tuberculosis, tracheal stenosis is unavoidable in these settings, but the therapeutic regimen triggers improvement of the respiratory pattern and reduction of symptoms. In the case reported, it was decided to start the empirical treatment for tuberculosis, obtaining a good clinical result, enabling termination of pregnancy. Background: Lung cancer is a major cause of cancer-related death worldwide. Gastrointestinal (GI) tract involvement in lung cancer is uncommon but well-documented. Method: We report an clinical case from the oncology department of the military hospital of Tunis about digestive metastases of a primary pulmonary adenocarcinoma while underlining the interest of cytoplasmic staining of carcinomatous cells with anti-cytokeratin 7, anti-cytokeratin 20 and anti-TTF1 antibodies (thyroid transcription factor -1). Results: A 64-year-old male active smoker at 40 year pack presented in the military hospital of Tunis with melena. PS was1. In June 2016, appearance of low digestive bleeding. Oeso-gastroduodenal fibroscopy was performed showing a range of gastric ulceration. The biopsies concluded in a well-differentiated adenocarcinoma whose immunohistochemical study revealed the presence of anti-CK7 and anti-TTF1 antibodies and the absence of anti-CK 20 and HER 2 antibodies. Colonoscopy revealed a suspicious polyp. Biopsies of this polyp confirmed the diagnosis of well-differentiated adenocarcinoma whose immunohistochemical study revealed positive labeling of carcinomatous cells with anti-ck7, anti-ck20 and anti-TTF1 antibodies. Primary duodenal adenocarcinoma or metastasis of lung carcinoma could be considered, but in view of this immunohistochemical profile, the pulmonary origin was the most likely. Hence the diagnosis of metastatic pulmonary adenocarcinoma was mentioned. A subsequent chest/abdominal CT scan was performed showing 2 lesions in the lower right lung lobe with multiple secondary lesions, peritoneal carcinomatosis associated with centimetric celiac and retroperitoneal lymphadenopathies. However, cerebral CT scan was without abnormalities. Following the diagnosis, the patient received chemotherapy with cisplatin and pemetrexed protocol. The evolution was marked by the increase of the digestive symptomatology after 4 cycles of chemotherapy justifying the realization of an early reassessment. The thoracoabdominopelvic CT showed firstly a regression of the lesion in the right lower pulmonary lobe and, on the other hand, a marked increase in intrahepatic secondary lesions without any change in the appearance of retro-peritoneal and left latero-aortic lymphadenopathy. IBecause of the discordant response, we discussed the concomitant existence of two different cancers. Bronchial fibroscopy was then performed showing no macroscopic abnormalities. The biopsy confirmed the diagnosis of an adenocarcinoma weakly expressing anti-TTF1 antibody compatible with bronchopulmonary localization. The biomolecular study of the EGFR mutation (Epidermal growth factor receptor) or ALK rearrangement was negative. Hepatic biopsy found an adenocarcinoma expressing only anti-CK7 and anti-TTF1 antibodies while anti-CK20 antibodies were negative. Conclusion: The presence of GI metastasis in lung cancer is associated with poor prognosis. The TTF-1, CK7 and CK20 staining is important for the diagnosis. Keyword: Lung adenocarcinoma, GI metastasis, digestive bleeding
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